IceCure Medical (ICCM) Competitors $1.12 -0.02 (-1.32%) Closing price 03:59 PM EasternExtended Trading$1.10 -0.02 (-1.78%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICCM vs. SMTI, NVRO, RCEL, NYXH, INGN, ELMD, DRTS, PDEX, LNSR, and BWAYShould you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include Sanara MedTech (SMTI), Nevro (NVRO), AVITA Medical (RCEL), Nyxoah (NYXH), Inogen (INGN), Electromed (ELMD), Alpha Tau Medical (DRTS), Pro-Dex (PDEX), LENSAR (LNSR), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry. IceCure Medical vs. Sanara MedTech Nevro AVITA Medical Nyxoah Inogen Electromed Alpha Tau Medical Pro-Dex LENSAR BrainsWay Sanara MedTech (NASDAQ:SMTI) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, community ranking, institutional ownership and media sentiment. Do insiders & institutionals have more ownership in SMTI or ICCM? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by company insiders. Comparatively, 2.4% of IceCure Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to SMTI or ICCM? In the previous week, Sanara MedTech's average media sentiment score of 0.50 beat IceCure Medical's score of 0.00 indicating that Sanara MedTech is being referred to more favorably in the media. Company Overall Sentiment Sanara MedTech Positive IceCure Medical Neutral Is SMTI or ICCM more profitable? Sanara MedTech has a net margin of -10.71% compared to IceCure Medical's net margin of -376.85%. Sanara MedTech's return on equity of -19.86% beat IceCure Medical's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.86% -10.91% IceCure Medical -376.85%-124.44%-87.70% Which has preferable valuation and earnings, SMTI or ICCM? Sanara MedTech has higher revenue and earnings than IceCure Medical. Sanara MedTech is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M3.02-$4.30M-$1.14-25.82IceCure Medical$3.29M18.97-$14.65M-$0.30-3.75 Which has more risk and volatility, SMTI or ICCM? Sanara MedTech has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Does the MarketBeat Community prefer SMTI or ICCM? IceCure Medical received 3 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 96.30% of users gave IceCure Medical an outperform vote while only 60.53% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes2360.53% Underperform Votes1539.47% IceCure MedicalOutperform Votes2696.30% Underperform Votes13.70% Do analysts recommend SMTI or ICCM? Sanara MedTech presently has a consensus target price of $48.50, suggesting a potential upside of 64.80%. IceCure Medical has a consensus target price of $2.50, suggesting a potential upside of 122.22%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts clearly believe IceCure Medical is more favorable than Sanara MedTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00IceCure Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummarySanara MedTech beats IceCure Medical on 10 of the 18 factors compared between the two stocks. Get IceCure Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICCM vs. The Competition Export to ExcelMetricIceCure MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$62.44M$4.04B$5.29B$7.35BDividend YieldN/A39.51%5.12%4.31%P/E Ratio-3.8827.6821.7117.77Price / Sales18.9747.07379.3997.68Price / CashN/A51.0838.2234.64Price / Book4.175.816.443.98Net Income-$14.65M$67.09M$3.21B$247.44M7 Day Performance-2.17%3.73%5.24%4.44%1 Month Performance-25.99%-6.28%-9.49%-7.73%1 Year Performance-12.79%13.19%11.01%1.28% IceCure Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICCMIceCure Medical2.2795 of 5 stars$1.13-1.3%$2.50+122.2%-12.3%$62.44M$3.29M-3.8860Positive NewsSMTISanara MedTech1.8633 of 5 stars$27.55-0.9%$48.50+76.0%-9.4%$245.25M$86.67M-27.8360High Trading VolumeNVRONevro0.8635 of 5 stars$5.85+0.1%$6.43+9.9%-53.9%$224.32M$408.52M-3.091,215Analyst ForecastRCELAVITA Medical1.3156 of 5 stars$7.76+3.5%$17.25+122.3%-7.0%$203.45M$64.25M-3.25130NYXHNyxoah2.0687 of 5 stars$5.71-6.1%$14.75+158.3%-35.3%$194.48M$4.52M-3.05110Short Interest ↑Gap DownINGNInogen3.0383 of 5 stars$7.09+0.7%$7.00-1.3%-0.7%$190.63M$335.71M-3.151,030Short Interest ↓News CoverageHigh Trading VolumeELMDElectromed1.1483 of 5 stars$22.16-1.0%$38.00+71.5%+56.3%$189.62M$59.63M29.55160Positive NewsDRTSAlpha Tau Medical2.694 of 5 stars$2.45-2.8%$8.00+226.5%-7.3%$172.43MN/A-5.7080Short Interest ↓Gap DownHigh Trading VolumePDEXPro-Dex1.5272 of 5 stars$52.87+3.9%$52.00-1.6%+229.7%$172.41M$61.00M26.30140Short Interest ↑Positive NewsGap DownHigh Trading VolumeLNSRLENSAR1.0926 of 5 stars$13.76-0.6%$15.00+9.0%+355.3%$162.22M$53.49M-9.42110Short Interest ↓High Trading VolumeBWAYBrainsWay3.6466 of 5 stars$8.61-2.7%$13.17+52.9%+63.4%$162.10M$41.02M86.11120Short Interest ↓Positive NewsGap Down Related Companies and Tools Related Companies SMTI Alternatives NVRO Alternatives RCEL Alternatives NYXH Alternatives INGN Alternatives ELMD Alternatives DRTS Alternatives PDEX Alternatives LNSR Alternatives BWAY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICCM) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share IceCure Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.